首页> 外文期刊>Retina >Presentation and outcome of patients with punctate inner choroidopathy at a tertiary referral center.
【24h】

Presentation and outcome of patients with punctate inner choroidopathy at a tertiary referral center.

机译:三级转诊中心出现点状内脉络膜病变的患者的表现和结局。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: : To describe the clinical course of patients with punctate inner choroidopathy seen at the University of Illinois, with emphasis on development of choroidal neovascularization (CNV). METHODS: : Patients with a diagnosis of punctate inner choroidopathy were identified retrospectively. The diagnosis was made clinically based on findings of multiple, small "punched-out" lesions in the posterior pole without intraocular inflammation. Medical records were evaluated for evidence of CNV. RESULTS: : Twelve patients with a diagnosis of punctate inner choroidopathy were identified. Average age at presentation was 32 years (range, 24-52 years). Eleven were women, and 11 were white. Eleven patients had available refractive data: 10 were myopic. Eight had CNV at initial presentation, and 1 later developed CNV. Eight had follow-up averaging 4 years (range, 1.4-9.6 years). Of these, five had CNV at initial presentation, and five developed new CNV. Four had multiple CNV membranes. All 6 patients with follow-up of >/=3 years had visual acuity at 3 years postpresentation of >20/40 in at least 1 eye. Four had visual acuity >20/40 bilaterally. CONCLUSION: : Of punctate inner choroidopathy patients in this series, 75% had CNV, and more than 30% developed multiple neovascular membranes. With treatment, all patients with follow-up of >/=3 years had >20/40 vision in at least 1 eye.
机译:目的:描述在伊利诺伊大学见到的点状内脉络膜病变患者的临床过程,重点是脉络膜新血管形成(CNV)的发展。方法:回顾性分析诊断为点状内脉络膜病变的患者。该诊断是根据发现的后极无眼内炎症的多个小“穿孔”病变进行临床诊断的。评估医疗记录以获取CNV证据。结果:鉴定出十二名患有点状内脉络膜病变的患者。演讲时的平均年龄为32岁(范围24-52岁)。妇女中有11名,白人是11名。 11名患者有可用的屈光数据:10名近视。最初出现时有8具CNV,后来有1具CNV。 8例平均随访4年(范围1.4-9.6年)。其中,有五个在最初展示时具有CNV,另外五个则开发了新的CNV。四个具有多个CNV膜。随访> / = 3年的所有6例患者在至少1眼出现3年后> 20/40时均具有视敏度。四个视力双侧> 20/40。结论:在该系列的点状内脉络膜病变患者中,有75%的患者患有CNV,超过30%的患者出现了多个新生血管膜。经过治疗,所有随访≥3年的患者至少有1只眼的视力> 20/40。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号